Matthew Joseph Mistilis

Title: Innovations by Matthew Joseph Mistilis

Introduction

Matthew Joseph Mistilis is an accomplished inventor based in Atlanta, GA. He has made significant contributions to the field of vaccine formulations, particularly focusing on thermally stable vaccines. His work aims to enhance the stability and efficacy of vaccines, which is crucial for public health.

Latest Patents

Matthew holds a patent for "Thermally stable vaccine formulations and microneedles." This patent provides formulations and methods for stabilizing antigens in dry solid vaccines. One aspect of his invention relates to dry solid formulations of influenza vaccines, which include excipients that impart stability to influenza antigens. Another aspect addresses dry solid formulations of measles vaccines, also incorporating excipients that stabilize the measles antigen. The formulations are designed for reconstitution in a physiologically acceptable liquid vehicle to create an injectable solution or suspension for patient administration. Additionally, they can be developed into dissolvable microneedles or coated microneedles, offering innovative delivery methods.

Career Highlights

Matthew is affiliated with the Georgia Tech Research Corporation, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to improve vaccine delivery and stability, which can have a lasting impact on global health initiatives.

Collaborations

Matthew collaborates with notable colleagues, including William Christopher Edens and Andreas Sebastian Bommarius. Their combined expertise contributes to the innovative research being conducted at Georgia Tech.

Conclusion

Matthew Joseph Mistilis is a key figure in the development of advanced vaccine formulations. His innovative work in thermally stable vaccines and microneedles represents a significant step forward in vaccine technology. The impact of his inventions could greatly enhance vaccine accessibility and effectiveness in the future.